These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
532 related articles for article (PubMed ID: 35091640)
1. Impact of vaccination on the COVID-19 pandemic in U.S. states. Chen X; Huang H; Ju J; Sun R; Zhang J Sci Rep; 2022 Jan; 12(1):1554. PubMed ID: 35091640 [TBL] [Abstract][Full Text] [Related]
2. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity. Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P Cells; 2021 Oct; 10(11):. PubMed ID: 34831172 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 pandemic and vaccination build herd immunity. Redwan EM Eur Rev Med Pharmacol Sci; 2021 Jan; 25(2):577-579. PubMed ID: 33577008 [No Abstract] [Full Text] [Related]
4. Population Immunity Against COVID-19 in the United States. Moghadas SM; Sah P; Shoukat A; Meyers LA; Galvani AP Ann Intern Med; 2021 Nov; 174(11):1586-1591. PubMed ID: 34516275 [TBL] [Abstract][Full Text] [Related]
5. Core Concept: Herd immunity is an important-and often misunderstood-public health phenomenon. McDermott A Proc Natl Acad Sci U S A; 2021 May; 118(21):. PubMed ID: 34011611 [No Abstract] [Full Text] [Related]
6. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia. McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236 [TBL] [Abstract][Full Text] [Related]
7. Herd immunization with childhood vaccination may provide protection against COVID-19. Yu Y Acta Microbiol Immunol Hung; 2020 Sep; 67(3):198-200. PubMed ID: 32986604 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Pfizer-BioNTech and Moderna Vaccines in Preventing SARS-CoV-2 Infection Among Nursing Home Residents Before and During Widespread Circulation of the SARS-CoV-2 B.1.617.2 (Delta) Variant - National Healthcare Safety Network, March 1-August 1, 2021. Nanduri S; Pilishvili T; Derado G; Soe MM; Dollard P; Wu H; Li Q; Bagchi S; Dubendris H; Link-Gelles R; Jernigan JA; Budnitz D; Bell J; Benin A; Shang N; Edwards JR; Verani JR; Schrag SJ MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1163-1166. PubMed ID: 34437519 [TBL] [Abstract][Full Text] [Related]
9. Model based estimation of the SARS-CoV-2 immunization level in austria and consequences for herd immunity effects. Bicher M; Rippinger C; Schneckenreither G; Weibrecht N; Urach C; Zechmeister M; Brunmeir D; Huf W; Popper N Sci Rep; 2022 Feb; 12(1):2872. PubMed ID: 35190590 [TBL] [Abstract][Full Text] [Related]
10. What Is Herd Immunity? Desai AN; Majumder MS JAMA; 2020 Nov; 324(20):2113. PubMed ID: 33074287 [No Abstract] [Full Text] [Related]
11. Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S. Gumel AB; Iboi EA; Ngonghala CN; Ngwa GA Front Public Health; 2021; 9():709369. PubMed ID: 34368071 [TBL] [Abstract][Full Text] [Related]
12. Herd immunity: challenges and the way forward in Korea. Oh J; Kim S; Ryu B; Shin M; Kim BI Epidemiol Health; 2021; 43():e2021054. PubMed ID: 34412446 [TBL] [Abstract][Full Text] [Related]
13. Five reasons why COVID herd immunity is probably impossible. Aschwanden C Nature; 2021 Mar; 591(7851):520-522. PubMed ID: 33737753 [No Abstract] [Full Text] [Related]
14. Analyses of Confirmed COVID-19 Cases Among Korean Military Personnel After Mass Vaccination. Shin DH; Oh HS; Jang H; Lee S; Choi BS; Kim D J Korean Med Sci; 2022 Jan; 37(3):e23. PubMed ID: 35040298 [TBL] [Abstract][Full Text] [Related]
15. Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination. Chen JM; Sun YX; Chen JW J Med Virol; 2020 Nov; 92(11):2453-2457. PubMed ID: 32525587 [TBL] [Abstract][Full Text] [Related]
16. Could COVID-19 be contained in poor populations by herd immunity rather than by strategies designed for affluent societies or potential vaccine(s)? Ruppel A; Halim MI; Kikon R; Mohamed NS; Saebipour MR Glob Health Action; 2021 Jan; 14(1):1863129. PubMed ID: 33397199 [No Abstract] [Full Text] [Related]
17. COVID-19 vaccines and herd immunity: Perspectives, challenges and prospects. Wong RSY Malays J Pathol; 2021 Aug; 43(2):203-217. PubMed ID: 34448786 [TBL] [Abstract][Full Text] [Related]
18. [Immunity against SARS-CoV-2: walking to the vaccination]. RodrÃguez Hernández C; Sanz Moreno L Rev Esp Quimioter; 2020 Dec; 33(6):392-398. PubMed ID: 32935536 [TBL] [Abstract][Full Text] [Related]
19. The Benefits of Vaccinating With the First Available COVID-19 Coronavirus Vaccine. Bartsch SM; O'Shea KJ; Wedlock PT; Strych U; Ferguson MC; Bottazzi ME; Randall SL; Siegmund SS; Cox SN; Hotez PJ; Lee BY Am J Prev Med; 2021 May; 60(5):605-613. PubMed ID: 33632650 [TBL] [Abstract][Full Text] [Related]
20. Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance - Eight U.S. Locations, December 2020-August 2021. Fowlkes A; Gaglani M; Groover K; Thiese MS; Tyner H; Ellingson K; MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(34):1167-1169. PubMed ID: 34437521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]